Skip to main content
Year archive

NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD — 2021 filings

All 84 regulatory filings released by NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD (NSB) in 2021, sourced directly from the official regulator.

84 Filings
2021 Period
2021 filings (84)
Filing Released Lang
Positive off-target safety assessment of EmtinB 2 pages 149.0KB
Regulatory Filings
2021-12-23 English
Positive results in biomarker characterisation of Emtins 4 pages 433.5KB
Capital/Financing Update
2021-12-20 English
Change of Director's Interest Notice 2 pages 271.2KB
Director's Dealing
2021-12-12 English
Change of Director's Interest Notice 3 pages 273.2KB
Director's Dealing
2021-12-12 English
Change of Director's Interest Notice 3 pages 268.9KB
Director's Dealing
2021-12-12 English
Change of Director's Interest Notice 3 pages 271.6KB
Director's Dealing
2021-12-12 English
Notification regarding unquoted securities - NSB 7 pages 30.4KB
Share Issue/Capital Change
2021-12-07 English
Notification regarding unquoted securities - NSB 7 pages 30.3KB
Share Issue/Capital Change
2021-12-07 English
Investor Webinar Presentation 13 pages 1.4MB
Investor Presentation
2021-12-02 English
NSB partners with leading diffusion MRI company Imeka 3 pages 299.3KB
Regulatory Filings
2021-11-21 English
Investor Webinar Presentation 13 pages 1.2MB
Investor Presentation
2021-11-17 English
Chairman's Address to Shareholders 16 pages 1.2MB
AGM Information
2021-11-10 English
Results of Meeting 3 pages 223.1KB
Declaration of Voting Results & Voting Rights Announcements
2021-11-10 English
Adoption of New Constitution 74 pages 759.5KB
Governance Information
2021-11-10 English
NSB Partners with Biospective for MS Studies 3 pages 228.8KB
Regulatory Filings
2021-11-01 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 288.0KB
Interim / Quarterly Report
2021-10-28 English
Company Presentation 24 pages 2.3MB
Investor Presentation
2021-10-25 English
Company Presentation - updated 24 pages 2.3MB
Investor Presentation
2021-10-25 English
Completion of Safety Pharmacology Studies 2 pages 147.9KB
Regulatory Filings
2021-10-17 English
Notice of Annual General Meeting/Proxy Form 39 pages 652.5KB
AGM Information
2021-10-10 English
Proposed issue of securities - NSB 6 pages 29.5KB
Capital/Financing Update
2021-10-10 English
Corporate Governance Statement 15 pages 234.5KB
Governance Information
2021-09-22 English
Appendix 4G 12 pages 266.5KB
Governance Information
2021-09-22 English
Date of AGM & Closing Date for Director Nominations 2 pages 159.8KB
AGM Information
2021-09-20 English
Broker Briefing Investor Webinar 1 page 127.2KB
Investor Presentation
2021-09-07 English
NSB Receives R&D Advance & Overseas Finding 2 pages 118.4KB
Capital/Financing Update
2021-09-02 English
Investor Webinar 2 pages 114.4KB
Investor Presentation
2021-09-02 English
Company Presentation 21 pages 2.0MB
Investor Presentation
2021-09-02 English
Positive Results in Multiple Sclerosis Study 5 pages 255.6KB
Capital/Financing Update
2021-08-30 English
2021 Annual Report and Appendix 4E 48 pages 934.8KB
Annual Report
2021-08-26 English
NSB appoints International Scientific Advisors 2 pages 143.4KB
Board/Management Information
2021-08-23 English
Results from Pulmonary Studies Clarification 5 pages 165.2KB
Regulatory Filings
2021-08-19 English
Results from Pulmonary Studies 3 pages 166.2KB
Regulatory Filings
2021-08-18 English
Pause in Trading 1 page 113.3KB
Regulatory Filings
2021-08-18 English
Trading Halt 2 pages 602.8KB
Regulatory Filings
2021-08-18 English
Quarterly Update and Appendix 4C 8 pages 359.4KB
Interim / Quarterly Report
2021-07-29 English
Change of Director's Interest Notice 2 pages 265.9KB
Director's Dealing
2021-07-12 English
Successful completion of pivotal ocular safety study 3 pages 175.0KB
Regulatory Filings
2021-06-30 English
Pause in Trading 1 page 112.3KB
Regulatory Filings
2021-06-29 English
Trading Halt 2 pages 604.7KB
Regulatory Filings
2021-06-29 English
Initial Director's Interest Notice 2 pages 240.4KB
Director's Dealing
2021-06-27 English
NSB partners with Linear Research for Phase I Clinical Study 2 pages 179.8KB
Regulatory Filings
2021-06-22 English
Gold Coast Investment Showcase Presentation 25 pages 2.2MB
Investor Presentation
2021-06-22 English
Appointment of Non-executive Chairman 3 pages 185.3KB
Board/Management Information
2021-06-21 English
Proposed issue of securities - NSB 6 pages 29.9KB
Capital/Financing Update
2021-06-21 English
R&D Tax Rebate Received 1 page 111.9KB
Regulatory Filings
2021-05-30 English
Appendix 3G 13 pages 282.6KB
Share Issue/Capital Change
2021-05-26 English
Final Director's Interest Notice 2 pages 258.6KB
Director's Dealing
2021-05-19 English
Change of Director's Interest Notice 3 pages 224.2KB
Director's Dealing
2021-05-17 English
Change of Director's Interest Notice 2 pages 222.6KB
Director's Dealing
2021-05-17 English
Change of Director's Interest Notice 3 pages 221.3KB
Director's Dealing
2021-05-17 English
Director Appointment/Resignation 1 page 106.2KB
Board/Management Information
2021-05-17 English
Update on Pivotal Ocular Safety Studies 3 pages 634.6KB
Regulatory Filings
2021-05-04 English
Appendix 4C - quarterly 7 pages 288.4KB
Interim / Quarterly Report
2021-04-29 English
Manufacturing Update 1 page 86.4KB
Regulatory Filings
2021-04-27 English
Key Executive Appointments to Support Clinical Studies 2 pages 113.7KB
Board/Management Information
2021-03-30 English
Strong Investor Support for Exercise of Listed Options 1
Capital/Financing Update
2021-03-10 English
Appendix 2A 15 pages 301.7KB
Capital/Financing Update
2021-03-10 English
Change in substantial holding 3 pages 210.8KB
Major Shareholding Notification
2021-03-10 English
Appendix 2A 15 pages 297.3KB
Capital/Financing Update
2021-03-07 English
Change of Director's Interest Notice 3 pages 223.9KB
Director's Dealing
2021-03-02 English
Appendix 2A 15 pages 300.3KB
Regulatory Filings
2021-03-02 English
Change of Director's Interest Notice 4 pages 225.9KB
Director's Dealing
2021-02-25 English
Appendix 2A 15 pages 300.5KB
Regulatory Filings
2021-02-25 English
Appendix 2A 15 pages 300.5KB
Capital/Financing Update
2021-02-23 English
Half Yearly Report and Accounts 16 pages 465.0KB
Interim / Quarterly Report
2021-02-22 English
Appendix 2A 15 pages 300.4KB
Capital/Financing Update
2021-02-17 English
Change of Director's Interest Notice 3 pages 224.8KB
Director's Dealing
2021-02-17 English
Appendix 2A 15 pages 300.5KB
Capital/Financing Update
2021-02-15 English
Appendix 2A 15 pages 299.3KB
Capital/Financing Update
2021-02-11 English
Appendix 2A 15 pages 299.1KB
Share Issue/Capital Change
2021-02-04 English
Change in substantial holding 3 pages 232.4KB
Major Shareholding Notification
2021-02-04 English
Appendix 4C - quarterly 7 pages 307.7KB
Interim / Quarterly Report
2021-01-28 English
Appendix 2A 15 pages 300.4KB
Share Issue/Capital Change
2021-01-28 English
Last Date of Quotation of Listed Options 1 page 105
Capital/Financing Update
2021-01-26 English
Expiry of Listed Options 3 pages 540.8KB
Regulatory Filings
2021-01-24 English
Appendix 2A 15 pages 300.2KB
Capital/Financing Update
2021-01-21 English
Appendix 3G 12 pages 279.0KB
Capital/Financing Update
2021-01-14 English
Appendix 3Y 3 pages 189.3KB
Director's Dealing
2021-01-14 English
Appendix 3Y 2 pages 185.5KB
Director's Dealing
2021-01-14 English
Appendix 3Y 3 pages 185.9KB
Director's Dealing
2021-01-14 English
Appendix 3Y 3 pages 187.1KB
Director's Dealing
2021-01-14 English
Appendix 2A 15 pages 300.2KB
Regulatory Filings
2021-01-14 English
Appendix 2A 15 pages 299.9KB
Capital/Financing Update
2021-01-07 English